USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Institute OF Basic Medical Sciences Chinese Academy OF Medical Sciences

Q: Where does Institute OF Basic Medical Sciences Chinese Academy OF Medical Sciences rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Institute OF Basic Medical Sciences Chinese Academy OF Medical Sciences ranks #24,559 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

Q: How is the Institute OF Basic Medical Sciences Chinese Academy OF Medical Sciences patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO PatentsView assignee record - 11 granted patents across 10 technology areas, recorded in grant years 2017–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Institute ranks #24,559 of 49,997 tracked US assignees by granted-patent volume, with 11 patents across 10 technology areas.

#24,559
of 49,997 US assignees by volume: 41st percentile
by Innovation Score (32.3/100): 12.0
avg claims per patent: +300%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R24559 · Foreign Corporation #24,559 · 11 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-FOCUS · INNOV-THIN · CLAIMS-RICH · TYPE-FRNCORP · VEL-SURGE · BOOK-FULL

GRANTS-MICRO 11 grants
MID-PACK #24,559/49,997
PHOTO-FINISH Infoseize Systems
CPC-FOCUS A61P · 10 areas
INNOV-THIN 32.3/100
CLAIMS-RICH 12.0 claims/avg
TYPE-FRNCORP Foreign Corp
VEL-SURGE +300% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Infoseize Systems Co. Ltd. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Institute’s 32.3 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 8.6 pts (27%) Velocity 5.3 pts (16%) Breadth 11.2 pts (35%) Claim depth 7.2 pts (22%)

Qualcomm Incorporated · highest

85
Institute OF Basic… · this assignee

32
3D Lighting… · lowest

7

What this shows Institute's Innovation Score is 32.3/100 (41st percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Institute?

Each dot is one of Institute’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Institute’s own 12.0 claims/patent is ABOVE the 9.0 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Institute vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Institute's grants concentrate

Institute OF Basic Medical Sciences Chinese Academy OF Medical Sciences is a focused PatentsView assignee: 10 CPC subclasses with 90.9% of grants classified under A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations). Peak complete grant year is 2021 (4 grants) versus a trough of 1 in 2017. By volume, Institute sits between Infoseize Systems Co. Ltd. and Integrated Composite Products, Inc..

Institute's three-year grant acceleration

Institute OF Basic Medical Sciences Chinese Academy OF Medical Sciences shows 4 grants in 2022–2024 against only 5 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Infoseize Systems

11
Innovative MED Co…

11
Insidesales COM

11
Institut Mines Te…

11
Institute OF Food…

11
Institute OF Nucl…

11
Institute OF Zool…

11
Integrated Compos…

11
Institute OF Basi… ◀

11

What this shows Institute holds 11 patents at rank #24,522, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Institute

By rank, the assignees closest to #24,522 in granted patent volume.

Leaders in A61P (Specific Therapeutic Activity OF Chemical Compounds OR Me…)

Other assignees with the most granted patents in Institute's primary technology class.

Institute's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

32 41st percentile higher than 41% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2017–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2017–2019 baseline. Full figures in the table below.

View data table

Institute OF Basic Medical Sciences Chinese Academy OF Medical Sciences patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2017	1	9.1%
2019	1	9.1%
2021	4	36.4%
2022	1	9.1%
2024	3	27.3%
2025partial year	1	9.1%

Which technologies does Institute OF Basic Medical Sciences Chinese Academy OF Medical Sciences patent most?

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 10

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 10

C12N - Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media 5

C07K - Peptides 3

Y02A - Technologies FOR Adaptation TO Climate Change 2

C07F - Acyclic, Carbocyclic OR Heterocyclic Compounds Containing Elements Other Than Carbon, Hydrogen, Halogen, Oxygen, Nitrogen, Sulfur, Selenium OR Tellurium 1

C07B - General Methods OF Organic CHEMISTRY; Apparatus Therefor 1

C07C - Acyclic OR Carbocyclic Compounds 1

C12Y - Enzymes 1

G01Q - Scanning-probe Techniques OR APPARATUS; Applications OF Scanning-probe Techniques, e.g. Scanning Probe Microscopy [SPM] 1

Top 10 of 10 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Institute OF Basic Medical Sciences Chinese Academy OF Medical Sciences's patent record in context - here's where to go next.

Institute OF Basic Medical Sciences Chinese Academy OF Medical Sciences's lead technology class is A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations), 90.9% of its portfolio - see every assignee active in that class. Explore A61P
Ranked #24,559 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Institute OF Basic Medical Sciences Chinese Academy OF Medical Sciences against Infoseize Systems Co. Ltd., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 32.3/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.